Clinical Trial Update: Sirolimus in Treating Patients With Advanced Pancreatic Cancer [Phase 2]

View source ↗

Summary

A Phase 2 trial evaluating sirolimus for advanced pancreatic cancer has completed and results were posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Pancreatic Cancer

Drugs mentioned

• Sirolimus (Sirolimus)

Snippet

Sponsor: Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins | Conditions: Pancreatic Cancer | Phase 2 | Status: COMPLETED | Results posted: 2016-10-19